PT - JOURNAL ARTICLE AU - Hurford, Amy AU - Martignoni, Maria M. AU - Loredo-Osti, J.C. AU - Anokye, Franics AU - Arino, Julien AU - Husain, Bilal Saleh AU - Gaas, Brian AU - Watmough, James TI - Pandemic modelling for regions implementing an elimination strategy AID - 10.1101/2022.07.18.22277695 DP - 2022 Jan 01 TA - medRxiv PG - 2022.07.18.22277695 4099 - http://medrxiv.org/content/early/2022/07/18/2022.07.18.22277695.short 4100 - http://medrxiv.org/content/early/2022/07/18/2022.07.18.22277695.full AB - During the COVID-19 pandemic, some countries, such as Australia, China, Iceland, New Zealand, Thailand and Vietnam, successfully implemented an elimination strategy. Until June 2021, Atlantic Canada and Canada’s territories had also experienced prolonged periods with few SARS-CoV-2 community cases. Such regions had a need for epidemiological models that could assess the risk of SARS-CoV-2 outbreaks, but most existing frameworks are applicable to regions where SARS-CoV-2 is spreading in the community, and so it was necessary to adapt existing frameworks to meet this need. We distinguish between infections that are travel-related and those that occur in the community, and find that in Newfoundland and Labrador (NL), Nova Scotia, and Prince Edward Island the mean percentage of daily cases that were travel-related was 80% or greater (July 1, 2020 – May 31, 2021). We show that by December 24, 2021, the daily probability of an Omicron variant community outbreak establishing in NL was near one, and nearly twice as high as the previous high, which occurred in September 2021 when the Delta variant was dominant. We evaluate how vaccination and new variants might affect hypothetical future outbreaks in Mt. Pearl, NL. Our modelling framework can be used to evaluate alternative plans to relax public health restrictions when high levels of vaccination are achieved in regions that have implemented an elimination strategy.Competing Interest StatementAH, MM, and JL-O were members of the Newfoundland and Labrador Predictive Analytics Modelling team and AH received funding from the Newfoundland and Labrador Department of Health and Community Services. Some data was provided by the Newfoundland and Labrador Center for Health Information. This work was not influenced by representatives of the Government of Newfoundland and Labrador.Funding StatementThis study was funded by the Emerging Infectious Disease Modelling Initiative Consortium (Canadian Network for Modelling Infectious Disease, Mathematics for Public Health, and the One Health Modelling Network for Emerging Infections). AH and MM received a grant from the Department of Health and Community Services, Newfoundland and Labrador.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Health Research Ethics Board of Newfoundland and Labrador gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll publicly available data used in this study are available at https://github.com/ahurford/pandemic-COVID-zero, but until the work completes peer-review please request these data and code by emailing ahurford@mun.ca